Bladder Cancer Clinical Trial

Bladder Cancer Patient-Reported Outcomes

Summary

The purpose of this study is to identify aspects of the bladder cancer (BlCa) survivorship experience that differ by clinical risk at diagnosis. The investigators will collect cross-sectional data from persons with BlCa to identify aspects of health-related quality of life (HRQOL) and symptom management. The study originally enrolled only nonmuscle-invasive bladder cancer survivors but has been expanded to include survivors with any stage disease. Information from this study will be used to develop a new patient education and counseling intervention.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

> 18 years
Diagnosed with BlCa within the past 4 years
Able to read, speak, and understand English
Able to provide informed consent.

Exclusion Criteria:

Younger than 18
Diagnosed BlCa longer than 4 years ago
Unable to read, speak, and understand English
Unable to provide informed consent.

Study is for people with:

Bladder Cancer

Estimated Enrollment:

108

Study ID:

NCT01090388

Recruitment Status:

Completed

Sponsor:

Baylor College of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Baylor College of Medicine
Houston Texas, 77030, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

108

Study ID:

NCT01090388

Recruitment Status:

Completed

Sponsor:


Baylor College of Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider